TY - JOUR T1 - Epidemiological and clinical features of non tuberculous mycobacteria infection (NTM) in a five-year single centre experience JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2016.PA2572 VL - 48 IS - suppl 60 SP - PA2572 AU - Valentina Conio AU - Davide Piloni AU - Alessandro Cascina AU - Thomas Galasso AU - Barbara Fusar Poli AU - Francesca Cemmi AU - Amelia Grosso AU - Erica Gini AU - Federica Albicini AU - Federica Meloni AU - Angelo Guido Corsico Y1 - 2016/09/01 UR - http://erj.ersjournals.com/content/48/suppl_60/PA2572.abstract N2 - The incidence and prevalence of NTM disease are increasing globally. NTM disease has been previously reported mainly in immunocompromised patients, but nowadays seems to affect increasingly immunocompetent pts. Aims of this work are: retrospective evaluation of epidemiological, clinical and radiological features of the NTM pulmonary diseases observed at our Clinic from 2010 to 2014. based on this analysis, we designed an algorithm for future management of NTM in our Department - We considered isolates with typing identification and antibiogram and reviewed demographic data, comorbidities, chest CT and treatments. 35 NTM were isolated from 31 pts. Of those, 23 from bronchoalveolar lavage, 12 from other samples (bronchial aspirate, sputum, induced sputum and lung biopsy). 7/31 pts (22,5%) had no apparently known comorbidities/risk factors. The most common lung comorbidities were bronchiectasis (15/31 pts, 25,8%), while extra respiratory comorbidities were type 2 diabetes (7/31 pts, 22,5%) and cancer (6/31 pts, 19,3%). The most frequent chest CT alteration was “tree in bud” (14/31 pts, 40%). Since low uniformity in identification of NTM patients deserving treatment was found, we designed the enclosed algorithm to guide future decisions. We found a high rate of NTM infections in subjects without risk factors. Multidisciplinary discussion is highly recommended. ER -